Hao Lin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Immunology top 10%
- Immune cells in cancer
- interferon and immune responses
- Immunotherapy and Immune Responses
Papers in
-
- Plant-derived Lignans Synthesis and Bioactivity 3
- Circular RNAs in diseases 2
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Co-authors
- Hui Yang (1 shared paper)Li Sun (1 shared paper)An-Kang Hu (1 shared paper)Ying Mao (1 shared paper)Cynthia Ju (1 shared paper)Alvin M. Malkinson (1 shared paper)Elizabeth F. Redente (1 shared paper)Kevin S. Choo (1 shared paper)
- Journals
- BMC Cancer (2 papers)Cell Biochemistry and Biophysics (2 papers)Gene (1 paper)Journal of Cellular Biochemistry (1 paper)Natural Product Communications (1 paper)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Hao Lin
25 papers receiving 533 citations
Hao Lin's Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 163
- Immunology 227
- Oncology 170
- Molecular Biology 235
- Biotechnology 21
Countries citing papers authored by Hao Lin
This map shows the geographic impact of Hao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Lin more than expected).
Fields of papers citing papers by Hao Lin
This network shows the impact of papers produced by Hao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Lin. The network helps show where Hao Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 133 | |
| 2 | Harnessing innate immune pathways for therapeutic advancement in cancer Hit paper breakdown → | 2024 | 113 |
| 3 | 2014 | 59 | |
| 4 | 2018 | 55 | |
| 5 | 2014 | 20 | |
| 6 | 2019 | 19 | |
| 7 | 2018 | 17 | |
| 8 | 2019 | 15 | |
| 9 | 2017 | 14 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 12 | |
| 13 | 2013 | 7 | |
| 14 | 2013 | 7 | |
| 15 | 2016 | 7 | |
| 16 | 2015 | 6 | |
| 17 | 2015 | 6 | |
| 18 | 2011 | 6 | |
| 19 | 2011 | 5 | |
| 20 | 2011 | 5 |
About Hao Lin
Hao Lin is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pathology and Forensic Medicine, having authored 28 papers that have together received 544 indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Cancer Research and Treatments (4 papers), Virus-based gene therapy research (3 papers), Immune Response and Inflammation (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Plant-derived Lignans Synthesis and Bioactivity (3 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (163 citations), Immunology (227 citations), Oncology (170 citations), Molecular Biology (235 citations) and Biotechnology (21 citations). Hao Lin has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Hui Yang, Li Sun, An-Kang Hu, Ying Mao, Cynthia Ju, Alvin M. Malkinson, Elizabeth F. Redente, Kevin S. Choo, David J. Orlicky and Meredith A. Tennis. Their work appears in journals such as BMC Cancer, Cell Biochemistry and Biophysics, Gene, Journal of Cellular Biochemistry and Natural Product Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.